$24.99
+0 (+0%)
At Close: Jul 31, 2026
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Avanos Medical, Inc. (NYSE: AVNS)
08:45am, Tuesday, 17'th Mar 2026
NEW YORK, March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders. The investigation seeks
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
07:22pm, Wednesday, 11'th Mar 2026
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
05:28pm, Monday, 02'nd Mar 2026
ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financ
CardioGenics (OTCMKTS:CGNH) & Avanos Medical (NYSE:AVNS) Financial Review
01:46am, Monday, 02'nd Mar 2026
Avanos Medical (NYSE: AVNS - Get Free Report) and CardioGenics (OTCMKTS:CGNH - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on t
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
07:00am, Thursday, 26'th Feb 2026
Enters into Agreement with Bradley L. Radoff ALPHARETTA, Ga.
Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
01:55pm, Wednesday, 25'th Feb 2026
AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
12:27pm, Tuesday, 24'th Feb 2026
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
10:41am, Tuesday, 24'th Feb 2026
Avanos Medical (AVNS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
07:00am, Tuesday, 24'th Feb 2026
Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance Delivered full-year organic growth of 6% in strategic segments Expanded transformation initiatives expected
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
04:30pm, Monday, 16'th Feb 2026
ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full y
CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
08:00am, Tuesday, 03'rd Feb 2026
ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital Outp
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
02:36pm, Thursday, 29'th Jan 2026
AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
11:20am, Monday, 26'th Jan 2026
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pa
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
07:46pm, Tuesday, 13'th Jan 2026
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sign In
Buy AVNS